Serenoa repens for benign prostatic hyperplasia (Q24241144)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Serenoa repens for benign prostatic hyperplasia	scientific article

Statements

instance of

scholarly article

0 references

meta-analysis

0 references

review article

1 reference

stated in

Europe PubMed Central

title

Serenoa repens for benign prostatic hyperplasia (English)

0 references

main subject

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

Serenoa repens

object named as

Serenoa repens

1 reference

based on heuristic

inferred from title

author

Timothy J Wilt

series ordinal

4

object named as

Timothy J Wilt

0 references

author name string

James Tacklind

series ordinal

1

0 references

Roderick MacDonald

series ordinal

2

0 references

Indy Rutks

series ordinal

3

0 references

language of work or name

English

0 references

publication date

2009

0 references

published in

Cochrane Database of Systematic Reviews

0 references

issue

2

0 references

page(s)

CD001423

0 references

cites work

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

19 March 2017

Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

19 March 2017

Saw palmetto for benign prostatic hyperplasia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

19 March 2017

Serenoa repens for benign prostatic hyperplasia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

19 March 2017

Complementary and alternative medicine use among adults: United States, 2002

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

7 April 2017

Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

27 September 2017

Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

27 September 2017

Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

27 September 2017

Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

27 September 2017

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

27 September 2017

Plant extracts in BPH.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

27 September 2017

Treatment of benign prostatic hyperplasia with phytosterols

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

27 September 2017

Clinical manifestations of benign prostatic hyperplasia and indications for therapeutic intervention

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

27 September 2017

Clinical trials in psychiatry: should protocol deviation censor patient data?

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

27 September 2017

Phytotherapy for the prostate

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

27 September 2017

Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

30 May 2018

Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

30 May 2018

Comparison of finasteride (Proscar) and Serenoa repens (Permixon) in the inhibition of 5-alpha reductase in healthy male volunteers

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

30 May 2018

A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

30 May 2018

Symptomatic treatment of benign hypertrophy of the prostate. Comparative study of prazosin and serenoa repens

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

30 May 2018

The Assessment of Prostatic Obstruction from Urodynamic Measurements and from Residual Urine

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

30 May 2018

Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

21 January 2018

Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

21 January 2018

A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

21 January 2018

Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms--a placebo-controlled, double-blind, multicenter trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

21 January 2018

Randomized trial of a combination of natural products (cernitin, saw palmetto, B-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

21 January 2018

Long-Term Efficacy of <i>Serenoa repens</i> Treatment in Patients with Mild and Moderate Symptomatic Benign Prostatic Hyperplasia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

21 January 2018

BPH and inflammation: pharmacological effects of Permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

21 January 2018

Serenoa repens treatment modifies bax/bcl-2 index expression and caspase-3 activity in prostatic tissue from patients with benign prostatic hyperplasia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

21 January 2018

Saw palmetto alters nuclear measurements reflecting DNA content in men with symptomatic BPH: evidence for a possible molecular mechanism

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

21 January 2018

Phytotherapeutic agents in the treatment of lower urinary tract symptoms: a demographic analysis of awareness and use at the University of Chicago

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

21 January 2018

Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

21 January 2018

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

21 January 2018

Phytotherapy in treatment of benign prostatic hyperplasia: a critical review

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

21 January 2018

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

21 January 2018

Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

21 January 2018

Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: a comprehensive analysis of the pooled placebo groups of several large clinical trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

21 January 2018

Efficacy and safety of a combination of sabal and urtica extract in lower urinary tract symptoms. A randomized, double-blind study versus tamsulosin.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

29 November 2018

Efficacy of pretreatment with Serenoa repens on bleeding associated with transurethral resection of prostate

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

29 November 2018

Tamsulosin with or without Serenoa repens in benign prostatic hyperplasia: the OCOS trial

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

29 November 2018

Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090655

retrieved

29 November 2018

[Combination of Sabal and Urtica extract vs. finasteride in benign prostatic hyperplasia (Aiken stages I to II). Comparison of therapeutic effectiveness in a one year double-blind study]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The development of human benign prostatic hyperplasia with age

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Treatment of obstructive symptomatology caused by prostatic adenoma with an extract of Serenoa repens. Double-blind clinical study vs. placebo]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of permixon in benign prostatic hypertrophy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conservative, non-hormonal treatment of benign prostatic hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variance imputation for overviews of clinical trials with continuous response

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growing use of medicinal botanicals forces assessment by drug regulators

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme activities in tissue of human benign prostatic hyperplasia after three months' treatment with the Sabal serrulata extract IDS 89 (Strogen) or placebo

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in U.S. men

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Efficacy of a combined Sabal-urtica preparation in the symptomatic treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Combined extract of Sabal palm and nettle in the treatment of patients with lower urinary tract symptoms in double blind, placebo-controlled trial]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of saw palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized trial in Shanghai, China

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Saw palmetto fruit extract for treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract ofSerenoa repens (LSESr, Permixon�) in benign prostatic hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19370565

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The lipidosterolic extract of Serenoa repens in the treatment of benign prostatic hyperplasia: a comparison of two dosage regimens.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Early urodynamic effects of the lipido-sterolic extract of Serenoa repens (Permixon(R)) in patients with lower urinary tract symptoms due to benign prostatic hyperplasia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Associating Serenoa Repens, Urtica Dioica and Pinus Pinaster. Safety and Efficacy in the Treatment of Lower Urinary Tract Symptoms. Prospective Study on 320 Patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001423.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD001423.PUB2

0 references

PMC publication ID

3090655

0 references

PubMed publication ID

19370565

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24241144&oldid=1952875105"